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Greater Apparent Absorption of Flavonoids Is Associated with
Lesser Human Fecal Flavonoid Disappearance Rates
ANDREAN L. SIMONS, MATHIEU RENOUF, PATRICIA A. MURPHY, AND
SUZANNE HENDRICH*
Department of Food Science and Human Nutrition, Iowa State University, Ames, Iowa 50011
It was hypothesized that 5,7,40-OH-flavonoids disappeared more rapidly from human fecal incuba-
tions and were less absorbable by humans than flavonoids without 5-OH moieties. Anaerobic fecal
disappearance rates over 24 h were determined for 15 flavonoids in samples from 20 men and
13 women. In these anaerobic fecal mixtures, flavonoids with 5,7,40-OH groups, genistein, apigenin,
naringenin, luteolin, kaempferol, and quercetin (disappearance rate, k = 0.46 ( 0.10 h-1), and
methoxylated flavonoids, hesperetin and glycitein (k = 0.24 ( 0.21 h-1), disappeared rapidly
compared with flavonoids lacking 5-OH (e.g., daidzein, k = 0.07 ( 0.03 h-1). Apparent absorption
of flavonoids that disappeared rapidly from in vitro fecal incubations, genistein, naringenin,
quercetin, and hesperetin, was compared with that of daidzein, a slowly disappearing flavonoid,
in 5 men and 5 women. Subjects ingested 104 μmol of genistein and 62 μmol of daidzein (soy milk),
1549 μmol of naringenin and 26 μmol of hesperetin (grapefruit juice), and 381 μmol of quercetin
(onions) in three test meals, each separated by 1 week. Blood and urine samples were collected
over 24 h after each test meal. Plasma flavonoid concentrations ranged from 0.01 to 1 μM.
The apparent absorption, expressed as percentage of ingested dose excreted in urine, was
significantly less for naringenin (3.2 ( 1.7%), genistein (7.2 ( 4.6%), hesperetin (7.3 ( 3.2%),
and quercetin (5.6 ( 3.7%) compared with daidzein (43.4 ( 15.5%, p = 0.02). These data affirmed
the hypothesis that the 5,7,40-OH of flavonoids limited apparent absorption of these compounds in
humans.
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Flavonoids are polyphenolic compounds that are widely dis-
tributed in foods of plant origin (1). Daily intakes in humans range
froma fewmilligrams to 1 g (2). Flavonoids in fruits andvegetables
have been suggested to lower the risk of steroid-dependent
cancers (3). A recent meta-analysis showed that cocoa, tea, and
soy flavonoid intake reduced several heart disease risk factors (4) in
populations consuming large amounts of flavonoids, but other
flavonoids are not well-studied to date. Over 5000 flavonoids have
been identified to date and are divided into subclasses, which differ
in their heterocyclic C ring (5), including flavones, flavanones,
flavonols, and isoflavones (Figure 1). Substitution patterns on the
A and B rings with hydroxyl, methyl, methoxyl, O- and C-sugars,
acyl, prenyl, sulfate, and glucuronide groups provide additional
structural variation in each flavonoid subclass (5).
Flavonoid glycosides are their predominant forms in foods.
The glycosides are absorbed to a very limited extent (5 ) and
are cleaved by gut bacterial or human intestinal β-glycosi-
dases (6 ). Flavonoid aglycons are absorbed across the intes-
tinal mucosa and conjugated in the mucosa and liver by phase
II enzymes (UDP-glucuronosyltransferase, sulfotransferase,
and catechol-O-methyltransferase) (7 ). The flavonoids may
be excreted in the urine or bile. Bacteria in the lower intestine
hydrolyze the flavonoid conjugates after biliary excretion,
which results in reabsorption of the flavonoid aglycons and
enterohepatic recirculation (7 ,8 ). The gut bacteria apparently
also further degrade the aglycons (9 ).
Determination of the metabolism and bioavailability of flavo-
noids is crucial in the assessment of their health effects, especially
knowing the extent of absorption of intact flavonoid aglucons.
Apparent absorption and plasma concentrations of isoflavones
were strongly related to fecal contents of these compounds. Two
women who excreted 10-fold more isoflavones in feces than did
five other women also showed different apparent absorption of
isoflavones; plasma daidzein and genistein were similar in the two
high fecal isoflavone excreters, but daidzein was apparently
absorbed to a significantly greater extent than genistein in the
low fecal excreters (10). This laboratory has developed in vitro
human fecal fermentation systems to determine flavonoid dis-
appearance rate (10), identify fecal isoflavone metabolites, and
predict human bioavailability of these compounds (10-13). Slow
in vitro fecal disappearance rates of daidzein and genistein
corresponded to greater daidzein and genistein bioavailability
in human subjects, measured by the mean amount of isoflavones
recovered in urine as a percentage of ingested dose (11). The rate
*Address correspondence to this author at 220MacKay, Iowa State
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of fecal isoflavone disappearance in vitro depended on the
chemical structure of isoflavones (10, 11). Genistein, which has
a 5-OH, was degraded significantly nore quickly than daidzein,
which does not possess this structural feature (10), and in
most subjects, daidzein was significantly more bioavailable than
genistein, as reflected in urinary excretion (10, 13).
The chemical structure and substitution pattern of other
flavonoids, flavones, flavanones, and flavonols influenced their
in vitro anaerobic fecal disappearance rates (14). Although
numerous gut microbial metabolites may be formed from flavo-
noids, most evidence of bioactivity to date has focused on the
parent flavonoids. A recent study of flavonoids found predomi-
nantly in tea and onions showed that the plasma contents of the
various gut microbial flavonoid metabolites were insignificant
compared with the parent flavonoid aglycons and suggested that
the main biological effects of the flavonoids are probably attri-
butable to the parent compounds (15). In the present study, we
hypothesized that the chemical structure of flavonoids deter-
mined their rate of fecal disappearance in vitro and their apparent
absorption in humans.
MATERIALS AND METHODS
Subjects. Thirty-three subjects (20 male and 13 female) were recruited
from Iowa State University for the in vitro flavonoid degradation study.
The subjects’ ages ranged from 18 to 37 years (mean age = 25.6 (
4.4 years) with a body mass index (BMI) of 18.1-46.1 kg/m2 (mean
BMI = 23.7 ( 4.9 kg/m2), respectively. The ethnicities of the subjects
included 15 Caucasians, 7 Asian Indians, 7 Chinese, 3 African Americans,
and 1 African.
Ten (5 male and 5 female) of the 33 subjects participated in the human
bioavailability studies. These subjects were selected on the basis of a
moderate or low in vitro fecal daidzein disappearance phenotype (average
k = 0.053 ( 0.029 h-1) to attempt to limit interindividual variability in
flavonoid bioavailability (13). These subjects were 18-30 years of age
(mean age = 25.0 ( 4.0 years) with BMI of 18.1-29.1 kg/m2 (mean
BMI = 22.6 ( 3.3). The ethnicities included three Caucasians, three
Chinese, two Asian Indians, and two African Americans (Table 1). All
subjects were healthy and not taking any medication. Approval of
the study design was obtained from the Iowa State University
Human Subjects Research Committee in 2004. The subjects followed an
isoflavone-, flavonol-, and flavanone-free diet for 1 week before their
respective feedings. All subjectswere given oral andwritten instructions on
foods and beverages not to consume during each washout period based on
the flavonoid levels reported in the USDA database for the flavonoid
content of selected foods (16).
Reagents and Chemicals. Apigenin, naringenin, kaempferol, luteo-
lin, quercetin, flavone, chrysin, 7,40-dihydroxyflavone, 6,40-dihydroxyfla-
vone, 5,40-dihydroxyflavone, and 5,30-dihydroxyflavone were from
Indofine Chemical Co., Inc. (Hillsborough, NJ). Daidzein and 2,4,40-
trihydroxydeoxybenzoin (THB) were synthesized using the method of
Song et al. (17 ). Genistein was synthesized according to a modification
of the method of Chang et al. (18 ). HPLC grade acetonitrile,Figure 1. Flavonoid structures and numbering system.
Table 1. Subject Characteristics
subject ID sex BMI (kg/m2) age (years) gut transit time (h)
in vitro anaerobic fecal daidzein
degradation rate, k (h-1) ethnicity
114 F 23.2 22 40 ( 9 0.054 Caucasian
118a F 18.1 24 53c 0.120 Asian
119 F 22.7 30 67 ( 20 0.047 Asian
125 F 29.1 24 50c 0.037 African American
127b F 22.5 26 104c 0.046 African American
206 M 26.3 24 39 ( 6 0.017 Caucasian
212 M 20.7 18 23 ( 16 0.036 Asian Indian
217 M 20.7 30 23 ( 11 0.064 Asian
224 M 23.7 25 75c 0.030 Caucasian
229 M 19.0 27 65 ( 9 0.074 Asian Indian
female 23.1( 3.9 25( 3 63 ( 25 0.061
male 22.1( 2.9 25( 4 45 ( 24 0.044
overall 22.6 ( 3.3 25( 4 54 ( 25 0.053( 0.029
aDropped out after the soy milk feeding period from discomfort due to blood withdrawal. bDropped out during the onion feeding period. cMissing standard deviation values due
to difficulty observing the red dye or incomplete collection of samples.
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methanol, acetic acid, dimethyl sulfoxide (DMSO), and all other
chemicals were from Fisher Scientific (Fair Lawn, NJ). Milli-Q system
(Millipore Co., Bedford, MA) HPLC grade water was used to prepare
all solutions.
Flavonoid Degradation and Bioavailability Study Designs. All
microbial fermentation experiments to determine flavonoid degradation
rates were performed according to the method of Simons et al. (14), except
that the final concentrationof each flavonoidwas 100 μmol/L; incubations
were performedanaerobically over 24h.The humanbioavailability studies
of isoflavone, flavanone, and flavonol were performed on three separate
days with a 2 week washout period between each feeding. To attempt to
minimize intersubject variability, subjects were prescreened according to
fecal daidzein degradation rates, which separated into three significantly
different phenotypes by statistical cluster analysis: high (k = 0.40 (
0.14 h-1, n= 3), moderate (k= 0.10 ( 0.02 h-1, n= 10) and low (k=
0.04 ( 0.02 h-1, n = 20, p < 0.05). Ten of the 30 subjects showing
moderate and low fecal daidzein degradation phenotypes were recruited to
ingest flavonoid test meals (Table 1). The isoflavones genistein and
daidzein were provided from soy milk, flavanones naringenin and hesper-
etin were from grapefruit juice, and the flavonol quercetin was from
sauteed red onions. The ingested amount of soy milk or grapefruit juice
was 2 cups, containing 28mg of genistein and 16mgof daidzein, or 422mg
of naringenin and 8 mg of hesperetin, respectively (aglucon equivalents).
The sauteed onions (185 g), which provided 115 mg of quercetin, were fed
in a three-egg omelet. The subjects consumed each flavonoid source along
with carmine red (170 mg/capsule, NuCara Pharmacy, Waterloo, IA)
within 10 min for breakfast on the morning of the study. Other breakfast
items not containing flavonoids were provided (e.g., toast, bagels, cereal,
milk, eggs, and cheese). All flavonoid sources and food items were
purchased from local grocery stores. Baseline urine, blood, and fecal
samples were collected before each flavonoid feeding. All urine was
collected for 24 h into plastic containers in three fractions, 0-6, 6-12,
and 12-24 h. Blood samples (10 mL) were collected into vacuum tubes
containing EDTA at 2, 4, 6, 12, and 24 h after consumption of the
isoflavone and naringenin test meals. Blood samples were collected 1, 3, 5,
12, and 24 h after the quercetin feeding. All feces were collected until
carmine red was excreted. Urine and fecal samples were frozen at-20 C
until analysis. Blood samples were centrifuged at 3000g, 25 min, and 4 C
within 1 h of collection. The plasma was separated and stored at -80 C
until analysis. The subjects remained at the study site until the collection of
the 6 h blood sample, after which theywere allowed to leave and return for
collection of 12 and 24 h blood samples.
AnalyticalMethods. Flavonoid Analysis in Foods. Isoflavones in
soy milk were hydrolyzed and extracted according to the method of
Murphy et al. (19). One gram of freeze-dried and ground grapefruit juice
was extracted in 12mLof 1MHCl in a 125mLscrew-topErlenmeyer flask
for 2 h at 98 C with stirring. The solution was cooled, and 18 mL of
acetonitrile was added to the solution and stirred for 5 min. One milliliter
of this solutionwas filteredwith a 0.45 μmPTFE filter (AlltechAssociates,
Deerfield, IL) into an HPLC vial. Red onions were chopped and slightly
sauteed, before being cooked in a three-egg omelet. Portions of the omelet
were freeze-dried, homogenized, and extracted according to the method
described above for grapefruit juice. Total aglycons of each flavonoidwere
obtained by HPLC analysis (below).
Urine Analysis. Urine samples were pooled in 0-6, 6-12, and
12-24 h increments for each subject. Five milliliter samples were incu-
bated with 5 mL of 0.2 M sodium acetate buffer at pH 5.5 and 50 μL of
β-glucuronidase/sulfatase (H2 type, Sigma Chemical Co., St. Louis, MO)
for 18 h in a 37 C shaking water bath. Ten milliliters of 10 mM sodium
phosphate buffer at pH 7.0 was added to the incubation solution and
mixed well. The solution was applied to a 20mLExtrelut QE column (EM
Sciences, Gibbstown, NJ), and the columnwas eluted twice with 18mL of
ethyl acetate. The ethyl acetate collections were collected, pooled, and
dried on a rotary evaporator at 25 C. The residue was dissolved in 9.8 mL
of 20% ethanol in water and 200 μL of 1 N HCl. Five milliliters of this
mixture was loaded onto a preactivated SepPak C18 cartridge and washed
twice with 2mL ofMilli-Q water. The flavonoids were elutedwith 2mL of
80%methanol in water and filtered through a 0.45 μmPTFE filter into an
HPLC vial.
Plasma Analysis. One milliliter of plasma was incubated with 1 mL
of 0.2M sodiumacetate at pH5.5 and 50μLof glucuronidase/sulfataseH2
type for 20 h at 37 C on a shaking water bath. One milliliter of 10 mM
sodium phosphate buffer (pH 7.0) was added to the incubation solution
and mixed. The solution was added to a 5 mL Extrelut SE column
(EM Sciences) and the flavonoids eluted twice with 2 mL of ethyl acetate
into a 20mL test tube. The solventwas evaporated underN2, and the dried
residue was dissolved in 200 μL of 80%methanol and then filtered with a
0.45 μm PTFE filter into an HPLC vial.
HPLCAnalysis.ABeckmanCoulter (Fullerton,CA)HPLCsystem
was used for HPLC analysis consisting of a System Gold 126 solvent
module, a System Gold 508 autosampler, and a System Gold 168
photodiode array detector. Forty microliter samples were injected onto
a reversed-phase, 5 μm, C18 AM 303 column (250  4.6 mm) (YMC Co.
Ltd., Wilmington, NC). The mobile phase consisted of 0.1% glacial acetic
acid in water (A) and 0.1% glacial acetic acid in acetonitrile (B). Solvent B
was increased from 30 to 50% over 10min, increased to 100%over 7 min,
and held for 1 min. The gradient was recycled to 30% over 2 min, flow
rate = 1 mL/min. The wavelengths used for the preparation of standard
curves, detection, and quantification of flavonoid peaks were 254 nm for
isoflavones, flavonols, and flavones and 292 nm for flavanones, with LOD
of 10 nmol/L for all compounds. Integration of peak area responses and
evaluation of ultraviolet spectra were carried out using 32 Karat software
(Beckman Coulter Inc.).
Data Analysis. The ratio of peak area of a flavonoid to THB
(0.1 μmol/L) versus the flavonoid concentration was used as a standard
calibration curve to estimate the concentration of flavonoids in the in vitro
fecal fermentations and in foods. The rate of disappearance of flavonoids
in fecal fermentation mixtures was estimated by plotting ln(% remaining
flavonoid) versus time. The negative slope of this line was the apparent
first-order flavonoid disappearance rate constant. Flavonoid disappear-
ance phenotypes were identified using cluster analysis (20). Gut transit
time (GTT) was determined by the time after ingestion for carmine red to
appear in feces. GTT estimates were averaged for the three flavonoid
feedings. The amounts of flavonoids in urine and plasma were calculated
directly from external standard curves using flavonoids added to urine or
plasma (n = 3 samples) and extracted in the same manner as the
experimental samples with standard curves obtained by plotting peak
area versus concentration. Urinary and plasma recoveries, respectively,
were as follows: genistein, 84.0 ( 6.8 and 77.7 ( 5.2%; daidzein, 84.3 (
5.7 and 78.6( 4.7%; naringenin, 89.1( 3.9 and 84.2( 4.1%; hesperetin,
88.9 ( 5.3 and 81.6 ( 3.2%; quercetin, 69.7 ( 10.5 and 60.2 ( 8.8%.
Pharmacokinetic parameters were determined using a one-compartment
linear model. Bioavailability was calculated as total urinary flavonoid
excretion over 24 h, as a percentage of ingested dose. Plasma area under
curve (AUC0f24h) was calculated using the linear trapezoidal rule (21).
The peak plasma concentration (Cmax) and the time to reach it (tmax) were
taken directly from the data. The elimination half-life (t1/2) was calculated
as t1/2 = ln 2/k. Statistical evaluation of all experimental results was
performed using the SAS system (version 8.1, SAS Institute, Cary, NC).
Differences in flavonoid bioavailability, normalized AUCs, overall
and individual degradation rates of flavonoids, and daidzein degrada-
tion phenotypes were estimated using one-way ANOVA, general linear
models. All analyseswere performed in duplicate, and all data are reported
as mean ( SD. The statistical significance of all analyses was set at
R= 0.05.
RESULTS
In Vitro Flavonoid Degradation. Fecal disappearance rate
differences were analyzed for genistein, apigenin, naringenin,
kaempferol, luteolin, quercetin, myricetin, hesperetin, chry-
sin, flavone, daidzein, glycitein, 5,40-dihydroxyflavone, 6,40-
dihydroxyflavone, 7,40-dihydroxyflavone, and 5,30-dihydrox-
yflavone (Table 2). The 5,7,40-trihydroxyl flavonoids
(genistein, naringenin, apigenin, kaempferol, quercetin, and
luteolin) rapidly disappeared from the fecal incubations, k ∼
0.46( 0.10 h-1 (p< 0.0001), except for the 5,7,40-trihydroxyl
flavonoid myricetin (3,5,7,30,40,50-hexahydroxyflavone), with
k = 0.04 ( 0.03 h-1. The methylated flavonoids, hesperetin
and glycitein, rapidly disappeared with k = 0.24 ( 0.21
and 0.18 ( 0.09 h-1, respectively. All other flavonoids
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(chrysin, flavone, daidzein, 5,40-dihydroxyflavone, 6,40-dihy-
droxyflavone, 7,40-dihydroxyflavone, and 5,30-dihydroxy-
flavone) were slowly degraded, k ∼ 0.05 ( 0.03 h-1.
Isoflavone Bioavailability.After ingestion of soymilk, genistein
and daidzein plasma concentrations peaked ∼5 h after dosing,
with t1/2 of 2.1 and 1.1 h, respectively (Table 3). Peak concentra-
tionswere 0.7( 0.3 μmol/L for genistein and 1.0( 0.4 μmol/L for
daidzein. Mean apparent absorptions of genistein and daidzein
(flavonoid excreted in urine as a percentage of ingested dose) were
7.2 ( 4.8 and 42.6( 16.0%, respectively (Table 3). In vitro fecal
genistein disappearance rates of the 10 subjects clustered into
three significantly different groups (p<0.0001): high (k=1.28(
0.45 h-1, n=3), moderate (k= 0.35( 0.01 h-1, n= 3), and low
(k = 0.11 ( 0.07 h-1, n = 4, Figure 2A). Urinary genistein
excretion in low genistein degraders was 11.5( 4.9% of ingested
dose, significantly greater than urinary genistein excretion
in moderate (3.5 ( 1.6%) and high genistein degraders (4.9 (
1.2%, p < 0.05, Figure 2B). There was no difference in plasma
AUC of genistein across individuals of high, moderate, and low
genistein disappearance rates (high, 0.059 ( 0.14 μmol 3 h 3L
-1/
μmol ingested; moderate, 0.086 ( 0.061 μmol 3 h 3L
-1/μmol
ingested; and low, 0.114 ( 0.044 μmol 3 h 3L
-1/μmol ingested,
p> 0.1), nor did plasma genistein AUC differ significantly from
plasma AUC of daidzein per micromole ingested (Table 3).
Flavanone Bioavailability. After ingestion of grapefruit juice,
naringenin and hesperetin plasma concentrations peaked at
5.1 and 12 h, respectively, with peak plasma concentrations of
0.3( 0.2 and 0.05( 0.09 μmol/L, respectively (Table 3). Plasma
half-lives were 5.7 h for naringenin and 3.6 h for hesperetin. The
mean urinary excretion as percentage of ingested dose of nar-
ingenin was 3.2 ( 1.7%, and that for hesperetin in males was
7.3 ( 3.2%. Hesperitin was not recovered in females (Table 3).
In vitro fecal naringenin disappearance rates clustered into
three significant groups: high (mean k = 0.63 ( 0.20 h-1,
n = 2), moderate (mean k = 0.20 ( 0.01 h-1, n = 3), and low
(mean k = 0.05 ( 0.03 h-1, n = 4). There was no difference in
urinary naringenin excretion or plasma AUC across these three
phenotypic groups (p > 0.05). The in vitro fecal hesperetin
disappearance rates did not cluster into significantly different
subgroups (data not shown).
Flavonol Bioavailability. After the ingestion of cooked red
onion, plasma quercetin concentrations peaked at 1.5 h with
a half-life of ∼9 h. Mean peak plasma concentration was 0.8(
0.6 μmol/L, AUC of 6.1 ( 6.1 μmol 3 h/L (not corrected for
μmol intake). The pharmacokinetics of quercetin was different
from that of the other flavonoids, in that the mean time of peak
plasma concentration was 1.5 ( 1.3 h, and significantly earlier
than the other flavonoids with a mean tmax value of 4.4( 1.2 h
(p = 0.00064). The mean elimination half-life was 9 h and
ranged from 1 to 20 h compared to the half-lives of the other
flavonoids, which ranged from 1 to 6 h. Urinary excretion of
quercetin was 5.6% of ingested dose (Table 3). In vitro fecal
quercetin disappearance did not sort into distinct clusters (data
not shown).
Overall Flavonoid Bioavailability Comparison.When flavonoids
were compared per micromole ingested, plasmaAUCvalues were
not significantly different for genistein anddaidzein (Table 3). The
mean plasma AUC values for genistein and daidzein were
significantly greater than the AUC values for naringenin, querce-
tin, and hesperetin (p= 0.001). Naringenin had the least plasma
AUC and apparent absorption, both significantly less than all of
the other flavonoids tested (p < 0.0001, Table 3). Apparent
absorptions (urinary excretion) were not significantly different
between quercetin, hesperetin, and genistein (6.6%, p > 0.05).
The apparent absorption of daidzein was significantly greater
than that of the other flavonoids (p< 0.0001).
DISCUSSION
The flavonoids that were seemingly more rapidly degraded
in in vitro fecal incubations from 33 subjects included the
isoflavone genistein, the flavones apigenin and luteolin,
the flavonols quercetin and kaempferol, and the flavanone
naringenin. All of these flavonoids have hydroxyl groups on
the 5-, 7-, and 40-positions of the flavonoid backbone struc-
ture (Figure 1). These results confirmed previous results which
showed that 5,7,40-trihydroxyl flavonoids were most rapidly
degraded by fecal microbes from 11 human subjects
compared with flavonoids not having these structural
features (14 ). However, myricetin, which also has hydroxyl
groups in the 5-, 7-, and 40-positions, was not degraded
rapidly. The rapidly degraded 5,7,40-trihydroxyl flavonoids
in this study possessed three to five hydroxyl groups and were
similar in their hydrophobicity when analyzed by HPLC
(data not shown). Myricetin has six hydroxyl groups on
the flavonoid backbone structure and is much more hydro-
philic compared with other 5,7,40-trihydroxyl flavonoids,
which may hinder its bacterial degradation. Other flavonoids
that were rapidly degraded were the methoxylated isofla-
vone and flavanone, glycitein and hesperetin, respectively.
Table 2. In Vitro Anaerobic Human Fecal Flavonoid Degradation Rates
(n = 33 Subjects)
flavonoid
in vitro
degradation
rate (h-1) flavonoid
in vitro
degradation
rate (h-1)
hesperetin 0.75( 0.05aa chrysin 0.08( 0.05c
naringenin 0.47( 0.28b 5,40-dihydroxyflavone 0.08 ( 0.05c
genistein 0.38 ( 0.32b 5,30-dihydroxyflavone 0.07( 0.04c
apigenin 0.37( 0.18b flavone 0.07( 0.02c
quercetin 0.35( 0.31b daidzein 0.07( 0.03c
luteolin 0.21( 0.16b 7,40-dihydroxyflavone 0.05( 0.02c
glycitein 0.18( 0.09bc 6,40-dihydroxyflavone 0.04( 0.03c
kaempferol 0.12( 0.17b myricetin 0.04( 0.04c
a Letters indicate significant differences, p < 0.05.
Table 3. Bioavailability Parameters of Ingested Flavonoids in Human Subjectsa
isoflavone N
ingested
dose (μmol)
in vitro fecal
disappearance
rateb (h-1)
relative plasma AUC
(μmol 3 h/L/ μmol ingested) Cmax (μmol/L) tmax (h) t1/2 (h)
amount
excreted over
24 h (μmol)
apparent absorption
(urinary recovery)
(% of ingested dose)
genistein 10 103.6 0.55( 0.56a 0.088( 0.046a 0.7( 0.3 4.8( 3.0a 2.1( 1.6 7.9( 5.3 7.2( 4.8b
daidzein 10 61.8 0.05( 0.03b 0.210( 0.060a 1.0( 0.4 5.3( 0.9 a 1.1( 0.8 26.8 ( 10.1 42.6( 16.0a
naringenin 9 1549.5 0.23 ( 0.25a 0.002( 0.001c 0.3( 0.2 5.1( 1.6 a 5.7( 5.9 50.0( 27.7 3.2( 1.7c
hesperetinc 5 25.5 0.75( 0.05a 0.027( 0.035b 0.05( 0.09 12.0( 5.5 a 3.6( 4.9 0.9( 0.4 7.3( 3.2b
quercetin 8 380.5 0.35( 0.31a 0.016( 0.016b 0.8( 0.6 1.5 ( 1.3 b 9.1( 8.9 21.1( 4.4 5.6( 3.7b
aBioavailability parameter values are means ( standard deviations.Means in a column without a common letter are significantly different, p < 0.05. bDisappearance rates
measured prior to the feeding studies. cHesperetin was not recovered in female subjects.
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These methoxylated flavonoids were rapidly demethylated in
vitro before further microbial degradation, and their cal-
culated degradation rates were based on the demethylation
reaction, and not on disappearance of the demethylation
product. In an in vitro human fecal incubation mixture,
hesperetin was rapidly demethylated to eriodictyol, which
has a 5,7,40-trihydroxyl flavonoid structure. Eriodictyol
then rapidly disappeared, which supported our findings that
5,7,40-trihydroxyl flavonoids are rapidly degraded (data
not shown). Hesperetin was demethylated in an in vitro pig
cecum model to eriodictyol and then further degraded to
3-(3-hydroxyphenyl)propionic acid and phloroglucinol (22 ).
We showed that the major degradation pathway of glycitein
is demethylation to 6,7,40-trihydroxyl isoflavone (23 ).
Hesperetin disappeared significantly more rapdily than did
glycitein (Table 2), perhaps as a result of a more rapid
demethylation reaction from the 40-position in hesperetin
compared with the 6-position in glycitein. The methoxylated
isoflavones formononetin, biochanin A, and glycitein were
demethylated regardless of the position of the methoxyl
group, but demethylation rates were not reported (24 ).
Perhaps the 5-hydroxyl of hesperetin was responsible for this
faster reaction; hesperetin has a 5-hydroxyl group, and
glycitein does not.
Because 5,7,40-trihydroxyl flavonoids disappeared from fecal
incubations rapidly in vitro, we tested the hypothesis that the
compounds genistein, naringenin, quercetin, and hesperetin
would not be very absorbable in humans because these flavonoids
would be more likely to be degraded by gut microbes before
they could be absorbed, whereas flavonoids such as daidzein
lacking one of the 5-, 7-, and 40-hydroxyl groups would be
more absorbable because they disappear at a slower rate and
have more time to be absorbed compared with 5,7,40-trihydroxyl
flavonoids.
The apparent absorption of daidzein as reflected in urinary
excretion was significantly greater than that for genistein,
hesperitin, naringenin, and quercetin (Table 3). The difference
in absorption between daidzein and genistein agrees with
other studies of subjects ingesting similar doses of genistein
and daidzein in soy foods (see, e.g., ref25). Doses of∼97 μmol
of daidzein and 71 μmol of genistein resulted in an average
daidzein bioavailability of 19.8%, significantly greater than
the mean genistein bioavailability of 5.3% (25 ).
Apparent absorption of naringenin reflected in urinary
excretion was∼3% and significantly less than that of the other
flavonoids, hesperetin, genistein, and quercetin, that were
rapidly degraded in vitro in fecal samples (Table 2). The plasma
AUC of naringenin was also less than that of the other rapidly
degraded flavonoids (Table 3). Low naringenin bioavailability
was found in previous studies reporting 4-5% apparent
absorption (urinary excretion) from a single oral dose of
1837 μmol of pure naringin ingested by human subjects (26).
However, a wide range of 5-57% naringenin bioavailability
(as urinary excretion) was reported in six subjects ingesting
26 μmol of naringin/kg of body weight (27). Because our study
was the first to compare the apparent absorption of these
flavonoids, perhaps the far greater dose of naringenin than of
the other flavonoids may have limited naringenin uptake. The
small number of subjects in our study may have prevented an
ability to distinguish effects of interindividual variability in
putative gut microbial degradation of naringenin, as seen in
degradation rate clusters (see Results, above), on the uptake of
this compound.
Most of the available research on hesperetin bioavailability has
previously been determined from ingestion of orange juice,
because hesperetin is themajor flavanone in orange juice,whereas
naringenin predominates in grapefruit juice. Hesperetin bioavail-
ability ranged from 3 to 6% (26, 27), which roughly agrees
with the mean hesperetin bioavailability of 7% (Table 3). We
observed a sex difference in hesperetin bioavailability in that
hesperetin was not recovered in the urine or plasma of females, so
hesperetin bioavailability was based on the five males (Table 3).
The reason for the apparent lack of hesperitin absorption in
women is unknown. Perhaps there was sex-specific conversion of
hesperitin to a metabolite that was not detectable by our HPLC
analyses.
Apparent bioavailability of quercetin was ∼6% of ingested
dose. These data supported previous data of 6% quercetin
bioavailability, tmax= 0.68 h and t1/2 = 10.9 h, after 12 human
subjects ingested 331 μmol of quercetin in onions (28), a dose
comparablewith our study (381 μmol). Lesser apparent quercetin
absorption of 1% was shown after intake of 300 g of lightly fried
yellowonions in five subjects (29). The reason for the difference in
these bioavailability values is not clear, but may be due to
substances in the omelet or in red onions that facilitated the
absorption of quercetin.
Plasma AUCs of the flavonoids generally corresponded
with urinary excretion, except in the case of genistein.
Although plasma AUC of daidzein was >2-fold more than
that of genistein when expressed per μmicromoles ingested,
there was no significant difference in the AUC of genistein
and daidzein, perhaps because of great interindividual varia-
bility and small numbers of subjects. Because 4 of 10 subjects
had low fecal degradation rates for genistein (Figure 2), mean
plasma AUC for genistein may be expected to be more similar
to that for daidzein, on the basis of a previous study in which
plasma daidzein was either greater than or similar to plasma
genistein depending on the subset of subjects studied (10 ).
Two women who had ∼10-fold greater apparent absorption
Figure 2. In vitro fecal disappearance phenotypes for genistein and
correlation with urinary excretion: (A) cluster analysis of genistein in vitro
fecal disappearance rates; (B) amount of genistein excreted in urine after
24 h in subjects with high, moderate, and low in vitro fecal genistein
disappearance phenotypes (bars with different letters were significantly
different, p < 0.05).
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of both isoflavones absorbed both isoflavones to a similar
extent, whereas five other women who had lesser overall
isoflavone absorption showed greater absorption of daidzein
than of genistein (10 ).
We observed significant interindividual variation within
compounds in fecal flavonoid degradation rates in vitro
(Table 2). For all of the flavonoids except hesperetin and
quercetin, cluster analysis revealed three significant group-
ings (p < 0.0001, data not shown); high, moderate, and low
flavonoid disappearance rates. Low flavonoid degraders may
experience greater bioavailability of flavonoids compared
with high flavonoid degraders because, in the low flavonoid
degraders, the flavonoids have more time to be absorbed
before they disappear. For example, women (n=12) with low
fecal isoflavone disappearance rates experienced greater
apparent absorption of isoflavones over 24 h compared with
women with high fecal isoflavone disappearance rates (n =
13) (12 ). Although previous studies indicate that interindivi-
dual variability in fecal degradation rates is an important
factor in interpreting flavonoid bioavailability data (10-12 )
(Table 2), the current study showed differences across these
fecal degradation rate clusters only for the apparent absorp-
tion (urinary excretion) of genistein (Figure 2). A 2-fold
greater difference in fecal degradation rate corresponded
with ∼2-fold less absorption, and greater fecal degradation
rate did not further decrease genistein uptake. Although
similar differences across fecal degradation rate clusters
occurred for naringenin compared with genistein, perhaps
the high dose of naringenin prevented the observation of an
effect of these fecal degradation rate clusters on naringenin
uptake.
These results provide a partial explanation as to why flavo-
noids withminor differences in their chemical structuremay exert
different biological effects. Differences in flavonoid chemical
structures affect their apparent intestinal microbial degradation
and human intestinal uptake, which is a key factor in the
biological activity of flavonoids. A recent hamster study sup-
ported the importance of relative isoflavone absorption in deter-
mining the efficacy of a soy protein diet to lower cholesterol. Only
hamsters clustering as high absorbers as reflected in their urinary
excretion of isoflavones exhibited significant reduction of total
and non-HDL cholesterol compared with casein-fed controls;
these high absorbers accounted for the observed lowering of
cholesterol by the soy protein diet (30). More data are needed on
the relationship of flavonoid chemical structure to biological
effects across and within flavonoid subgroups, but, clearly,
intestinal microbial metabolism of these compounds must be
considered.
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